AMAmneal Pharmaceuticals AMRX · NASDAQ
$19.36 +0.94% (+$0.18)
- Market cap
- $6.18B
- Enterprise value
- $8.85B
- P/E
- 39.3x
- Forward P/E
- 18.5x
- PEG
- -
- P/S
- 2.0x
- P/FCF
- 74.4x
- EV/EBITDA
- 13.6x
- ROIC
- 14.3%
- Gross margin
- 39.3%
- Net margin
- 5.0%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 4.1x
- Beta
- 1.22
- Free float
- 45.0%
About the company
Amneal Pharmaceuticals, Inc. is an American pharmaceutical company focused on the development, manufacturing, and distribution of generic and specialty medications. The company specializes in a broad range of therapeutic areas, including cardiovascular diseases, neurological disorders, oncology, and more. Amneal also produces its own branded products targeting specific conditions. The company is known for its ability to provide affordable medications while continuing to develop innovative therapies.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chirag K. Patel
Employees
8,700
Headquarters
Bridgewater
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number